Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

Holly Hagan, Mary H. Latka, Jennifer V. Campbell, Elizabeth T. Golub, Richard S. Garfein, David A. Thomas, Farzana Kapadia, Steffanie A. Strathdee

Research output: Contribution to journalArticle

Abstract

Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

Original languageEnglish (US)
Pages (from-to)669-672
Number of pages4
JournalClinical Infectious Diseases
Volume42
Issue number5
DOIs
StatePublished - Mar 1 2006

Fingerprint

Virus Diseases
Drug Users
Hepacivirus
Injections
Drinking
RNA
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

Hagan, H., Latka, M. H., Campbell, J. V., Golub, E. T., Garfein, R. S., Thomas, D. A., ... Strathdee, S. A. (2006). Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clinical Infectious Diseases, 42(5), 669-672. https://doi.org/10.1086/499951

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. / Hagan, Holly; Latka, Mary H.; Campbell, Jennifer V.; Golub, Elizabeth T.; Garfein, Richard S.; Thomas, David A.; Kapadia, Farzana; Strathdee, Steffanie A.

In: Clinical Infectious Diseases, Vol. 42, No. 5, 01.03.2006, p. 669-672.

Research output: Contribution to journalArticle

Hagan, Holly ; Latka, Mary H. ; Campbell, Jennifer V. ; Golub, Elizabeth T. ; Garfein, Richard S. ; Thomas, David A. ; Kapadia, Farzana ; Strathdee, Steffanie A. / Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. In: Clinical Infectious Diseases. 2006 ; Vol. 42, No. 5. pp. 669-672.
@article{d833a734dcae42fdbeb5606de6b76a5a,
title = "Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities",
abstract = "Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96{\%} had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.",
author = "Holly Hagan and Latka, {Mary H.} and Campbell, {Jennifer V.} and Golub, {Elizabeth T.} and Garfein, {Richard S.} and Thomas, {David A.} and Farzana Kapadia and Strathdee, {Steffanie A.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1086/499951",
language = "English (US)",
volume = "42",
pages = "669--672",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

AU - Hagan, Holly

AU - Latka, Mary H.

AU - Campbell, Jennifer V.

AU - Golub, Elizabeth T.

AU - Garfein, Richard S.

AU - Thomas, David A.

AU - Kapadia, Farzana

AU - Strathdee, Steffanie A.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

AB - Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

UR - http://www.scopus.com/inward/record.url?scp=33144471501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33144471501&partnerID=8YFLogxK

U2 - 10.1086/499951

DO - 10.1086/499951

M3 - Article

C2 - 16447112

AN - SCOPUS:33144471501

VL - 42

SP - 669

EP - 672

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -